As a stem cell marker, LGR5 regulates Wnt/β-catenin signaling and contributes to tumor initiation, progression, and therapy resistance in cancers such as colorectal, gastric, liver, and ovarian cancer (Wang et al., 2025; Liu et al., 2018). The gene discussed is LGR5; the disease is ovarian carcinoma.